USD/CAD is currently trying to settle above the resistance at 1.2915 while the U.S. dollar is gaining some ground against a broad basket of currencies. The U.S. Dollar Index managed to settle above ...

CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, announced today results from a genomic substudy of the NHLBI-funded Prospective Multicenter Imaging Study for ...

CLEVELAND, OH — The age/sex/gene-expression score (ASGES) test known as Corus CAD (CardioDx) appears easy to incorporate and effective in excluding obstructive coronary artery disease (CAD) in ...

CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced that Palmetto GBA, a national contractor that administers Medicare benefits, has established coverage for ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — In stable symptomatic patients with suspected CAD, a precision testing strategy was linked to a 70% ...

PALO ALTO, CA--(Marketwired - Mar 10, 2014) - CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, today announced the publication of the IMPACT-PCP (Investigation ...

Blood-Based Test Has Potential to Improve Quality of Care and Lower Costs of Evaluation of Obstructive Coronary Artery Disease REDWOOD CITY, Calif. – CardioDx, Inc., a molecular diagnostics company ...